Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-30857.69% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BOLT · Mar 31, 2026
Bolt Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-219382General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-97.87% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-29234.62% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18573.08% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2096.15% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesSelf-history eligible
Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20245/6 normalizedLevel 3Sep 30, 20245/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20254/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -517.87%
- Current
- -30857.69%
- Delta
- -30339.82%
- Previous
- 0.07%
- Current
- -97.87%
- Delta
- -97.94%
- Previous
- -469.30%
- Current
- -29234.62%
- Delta
- -28765.31%
- Previous
- 370.80%
- Current
- 18573.08%
- Delta
- 18202.28%
- Previous
- 36.15%
- Current
- 2096.15%
- Delta
- 2060.00%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · BOLT state analogue 1 →Transitioned To · BOLT Fundamental State →Transitioned To · BOLT CASH_GENERATION_DECREASED →Transitioned To · BOLT GROWTH_DECREASED →Transitioned To · BOLT PROFITABILITY_DECREASED →Transitioned To · BOLT R_AND_D_INTENSITY_INCREASED →Transitioned To · BOLT SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.